These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18058865)

  • 1. The presence of halide salts influences the non-covalent interaction of MRI contrast agents and human serum albumin.
    Henrotte V; Muller RN; Bartholet A; Elst LV
    Contrast Media Mol Imaging; 2007; 2(5):258-61. PubMed ID: 18058865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of non-covalent interactions between paramagnetic complexes and human serum albumin by electrospray mass spectrometry.
    Henrotte V; Laurent S; Gabelica V; Elst LV; Depauw E; Muller RN
    Rapid Commun Mass Spectrom; 2004; 18(17):1919-24. PubMed ID: 15329857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecific binding of MRI contrast agents to human serum albumin: the case of Gd-(S)-EOB-DTPA (Eovist) and its (R) isomer.
    Vander Elst L; Chapelle F; Laurent S; Muller RN
    J Biol Inorg Chem; 2001 Feb; 6(2):196-200. PubMed ID: 11293414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents.
    Pascolo L; Cupelli F; Anelli PL; Lorusso V; Visigalli M; Uggeri F; Tiribelli C
    Biochem Biophys Res Commun; 1999 Apr; 257(3):746-52. PubMed ID: 10208854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
    Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
    Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nonenzymatic glycosylation on the magnetic resonance imaging (MRI) contrast agent binding to human serum albumin.
    Henoumont C; Laurent S; Muller RN; Vander Elst L
    J Med Chem; 2012 Apr; 55(8):4015-9. PubMed ID: 22420713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
    McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB
    J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.
    Laurent S; Elst LV; Muller RN
    Contrast Media Mol Imaging; 2006; 1(3):128-37. PubMed ID: 17193689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water-proton relaxation by a noncovalent albumin-binding gadolinium chelate: an NMRD study of a potential blood pool agent.
    Adzamli K; Spiller M; Koenig SH
    Acad Radiol; 2002 May; 9 Suppl 1():S11-6. PubMed ID: 12019842
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetics of the exchange reactions between Gd(DTPA)2-, Gd(BOPTA)2-, and Gd(DTPA-BMA) complexes, used as MRI contrast agents, and the triethylenetetraamine-hexaacetate ligand.
    Pálinkás Z; Baranyai Z; Brücher E; Rózsa B
    Inorg Chem; 2011 Apr; 50(8):3471-8. PubMed ID: 21405037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging.
    Cavagna FM; Maggioni F; Castelli PM; Daprà M; Imperatori LG; Lorusso V; Jenkins BG
    Invest Radiol; 1997 Dec; 32(12):780-96. PubMed ID: 9406019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorometry, a fast screening technique for non-covalent binding of contrast agents to human serum albumin?
    Zhou Q; Henoumont C; Vander Elst L; Laurent S; Muller RN
    Contrast Media Mol Imaging; 2013; 8(4):361-5. PubMed ID: 23613439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximizing the relaxivity of Gd-complex by synergistic effect of HSA and carboxylfullerene.
    Zhen M; Zheng J; Ye L; Li S; Jin C; Li K; Qiu D; Han H; Shu C; Yang Y; Wang C
    ACS Appl Mater Interfaces; 2012 Jul; 4(7):3724-9. PubMed ID: 22704586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.
    Caravan P; Cloutier NJ; Greenfield MT; McDermid SA; Dunham SU; Bulte JW; Amedio JC; Looby RJ; Supkowski RM; Horrocks WD; McMurry TJ; Lauffer RB
    J Am Chem Soc; 2002 Mar; 124(12):3152-62. PubMed ID: 11902904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
    Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N
    Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the philosophy of optimizing contrast agents. An analysis of 1H NMRD profiles and ESR lineshapes of the Gd(III)complex MS-325+HSA.
    Zhou X; Caravan P; Clarkson RB; Westlund PO
    J Magn Reson; 2004 Mar; 167(1):147-60. PubMed ID: 14987609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrocyclic paramagnetic agents for MRI: Determinants of relaxivity and strategies for their improvement.
    Fringuello Mingo A; Colombo Serra S; Baroni S; Cabella C; Napolitano R; Hawala I; Carnovale IM; Lattuada L; Tedoldi F; Aime S
    Magn Reson Med; 2017 Oct; 78(4):1523-1532. PubMed ID: 27791281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multilocus binding increases the relaxivity of protein-bound MRI contrast agents.
    Zhang Z; Greenfield MT; Spiller M; McMurry TJ; Lauffer RB; Caravan P
    Angew Chem Int Ed Engl; 2005 Oct; 44(41):6766-9. PubMed ID: 16173108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.